nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Sunburn—Vemurafenib—melanoma	0.0529	0.0529	CcSEcCtD
Verteporfin—Retinal haemorrhage—Carmustine—melanoma	0.0259	0.0259	CcSEcCtD
Verteporfin—Raised liver function tests—Dactinomycin—melanoma	0.0195	0.0195	CcSEcCtD
Verteporfin—Lacrimal structural disorder—Docetaxel—melanoma	0.0185	0.0185	CcSEcCtD
Verteporfin—Photopsia—Docetaxel—melanoma	0.0171	0.0171	CcSEcCtD
Verteporfin—Musculoskeletal pain—Vemurafenib—melanoma	0.0162	0.0162	CcSEcCtD
Verteporfin—Visual acuity reduced—Temozolomide—melanoma	0.0137	0.0137	CcSEcCtD
Verteporfin—Myasthenia—Carmustine—melanoma	0.0134	0.0134	CcSEcCtD
Verteporfin—Photosensitivity—Vemurafenib—melanoma	0.0132	0.0132	CcSEcCtD
Verteporfin—Hyperaesthesia—Bleomycin—melanoma	0.0123	0.0123	CcSEcCtD
Verteporfin—Atrial fibrillation—Vemurafenib—melanoma	0.0122	0.0122	CcSEcCtD
Verteporfin—Lacrimal disorder—Docetaxel—melanoma	0.0121	0.0121	CcSEcCtD
Verteporfin—Raised liver function tests—Docetaxel—melanoma	0.0118	0.0118	CcSEcCtD
Verteporfin—Scotoma—Carmustine—melanoma	0.0111	0.0111	CcSEcCtD
Verteporfin—Extravasation—Bleomycin—melanoma	0.0111	0.0111	CcSEcCtD
Verteporfin—Scotoma—Temozolomide—melanoma	0.0107	0.0107	CcSEcCtD
Verteporfin—Hyperaesthesia—Temozolomide—melanoma	0.0104	0.0104	CcSEcCtD
Verteporfin—Injection site pain—Carmustine—melanoma	0.0103	0.0103	CcSEcCtD
Verteporfin—Extravasation—Dactinomycin—melanoma	0.0103	0.0103	CcSEcCtD
Verteporfin—Extravasation—Carmustine—melanoma	0.00968	0.00968	CcSEcCtD
Verteporfin—Photosensitivity reaction—Vemurafenib—melanoma	0.00914	0.00914	CcSEcCtD
Verteporfin—Hearing impaired—Temozolomide—melanoma	0.00857	0.00857	CcSEcCtD
Verteporfin—Injection site reaction—Carmustine—melanoma	0.00839	0.00839	CcSEcCtD
Verteporfin—Musculoskeletal pain—Temozolomide—melanoma	0.00826	0.00826	CcSEcCtD
Verteporfin—Dry eye—Temozolomide—melanoma	0.00754	0.00754	CcSEcCtD
Verteporfin—Eye disorder—Vemurafenib—melanoma	0.00749	0.00749	CcSEcCtD
Verteporfin—Cardiac disorder—Vemurafenib—melanoma	0.00744	0.00744	CcSEcCtD
Verteporfin—Angiopathy—Vemurafenib—melanoma	0.00727	0.00727	CcSEcCtD
Verteporfin—Scotoma—Docetaxel—melanoma	0.00714	0.00714	CcSEcCtD
Verteporfin—Malnutrition—Vemurafenib—melanoma	0.00698	0.00698	CcSEcCtD
Verteporfin—Back pain—Vemurafenib—melanoma	0.00675	0.00675	CcSEcCtD
Verteporfin—Extravasation—Docetaxel—melanoma	0.00622	0.00622	CcSEcCtD
Verteporfin—Diplopia—Carmustine—melanoma	0.00613	0.00613	CcSEcCtD
Verteporfin—Cough—Vemurafenib—melanoma	0.00609	0.00609	CcSEcCtD
Verteporfin—Liver function test abnormal—Dactinomycin—melanoma	0.00604	0.00604	CcSEcCtD
Verteporfin—Arthralgia—Vemurafenib—melanoma	0.00594	0.00594	CcSEcCtD
Verteporfin—Diplopia—Temozolomide—melanoma	0.00592	0.00592	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.0059	0.0059	CcSEcCtD
Verteporfin—Hearing impaired—Docetaxel—melanoma	0.0057	0.0057	CcSEcCtD
Verteporfin—Liver function test abnormal—Carmustine—melanoma	0.00566	0.00566	CcSEcCtD
Verteporfin—Inflammation—Docetaxel—melanoma	0.00559	0.00559	CcSEcCtD
Verteporfin—Nervous system disorder—Vemurafenib—melanoma	0.00559	0.00559	CcSEcCtD
Verteporfin—Skin disorder—Vemurafenib—melanoma	0.00553	0.00553	CcSEcCtD
Verteporfin—Pneumonia—Bleomycin—melanoma	0.00544	0.00544	CcSEcCtD
Verteporfin—Muscular weakness—Carmustine—melanoma	0.0054	0.0054	CcSEcCtD
Verteporfin—Injection site reaction—Docetaxel—melanoma	0.00539	0.00539	CcSEcCtD
Verteporfin—Acute coronary syndrome—Bleomycin—melanoma	0.00533	0.00533	CcSEcCtD
Verteporfin—Myocardial infarction—Bleomycin—melanoma	0.0053	0.0053	CcSEcCtD
Verteporfin—Muscular weakness—Temozolomide—melanoma	0.00522	0.00522	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00519	0.00519	CcSEcCtD
Verteporfin—Pneumonia—Dactinomycin—melanoma	0.00508	0.00508	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Vemurafenib—melanoma	0.00492	0.00492	CcSEcCtD
Verteporfin—Haemoglobin—Bleomycin—melanoma	0.00488	0.00488	CcSEcCtD
Verteporfin—Constipation—Vemurafenib—melanoma	0.00487	0.00487	CcSEcCtD
Verteporfin—Haemorrhage—Bleomycin—melanoma	0.00486	0.00486	CcSEcCtD
Verteporfin—Hypoaesthesia—Bleomycin—melanoma	0.00483	0.00483	CcSEcCtD
Verteporfin—Pneumonia—Carmustine—melanoma	0.00475	0.00475	CcSEcCtD
Verteporfin—Photosensitivity reaction—Temozolomide—melanoma	0.00467	0.00467	CcSEcCtD
Verteporfin—Pneumonia—Temozolomide—melanoma	0.00459	0.00459	CcSEcCtD
Verteporfin—Flushing—Bleomycin—melanoma	0.00451	0.00451	CcSEcCtD
Verteporfin—Body temperature increased—Vemurafenib—melanoma	0.0045	0.0045	CcSEcCtD
Verteporfin—Pharyngitis—Dactinomycin—melanoma	0.0045	0.0045	CcSEcCtD
Verteporfin—Haemoglobin—Carmustine—melanoma	0.00426	0.00426	CcSEcCtD
Verteporfin—Haemorrhage—Carmustine—melanoma	0.00424	0.00424	CcSEcCtD
Verteporfin—Hypoaesthesia—Carmustine—melanoma	0.00422	0.00422	CcSEcCtD
Verteporfin—Flushing—Dactinomycin—melanoma	0.0042	0.0042	CcSEcCtD
Verteporfin—Hypersensitivity—Vemurafenib—melanoma	0.0042	0.0042	CcSEcCtD
Verteporfin—Visual disturbance—Docetaxel—melanoma	0.00416	0.00416	CcSEcCtD
Verteporfin—Atrial fibrillation—Docetaxel—melanoma	0.00416	0.00416	CcSEcCtD
Verteporfin—Dermatitis bullous—Docetaxel—melanoma	0.00412	0.00412	CcSEcCtD
Verteporfin—Haemoglobin—Temozolomide—melanoma	0.00412	0.00412	CcSEcCtD
Verteporfin—Haemorrhage—Temozolomide—melanoma	0.0041	0.0041	CcSEcCtD
Verteporfin—Asthenia—Vemurafenib—melanoma	0.00409	0.00409	CcSEcCtD
Verteporfin—Visual impairment—Carmustine—melanoma	0.00409	0.00409	CcSEcCtD
Verteporfin—Hypoaesthesia—Temozolomide—melanoma	0.00408	0.00408	CcSEcCtD
Verteporfin—Pharyngitis—Temozolomide—melanoma	0.00407	0.00407	CcSEcCtD
Verteporfin—Pruritus—Vemurafenib—melanoma	0.00403	0.00403	CcSEcCtD
Verteporfin—Eye disorder—Carmustine—melanoma	0.00396	0.00396	CcSEcCtD
Verteporfin—Visual impairment—Temozolomide—melanoma	0.00395	0.00395	CcSEcCtD
Verteporfin—Flushing—Carmustine—melanoma	0.00393	0.00393	CcSEcCtD
Verteporfin—Ill-defined disorder—Bleomycin—melanoma	0.00392	0.00392	CcSEcCtD
Verteporfin—Anaemia—Bleomycin—melanoma	0.00391	0.00391	CcSEcCtD
Verteporfin—Eye disorder—Temozolomide—melanoma	0.00383	0.00383	CcSEcCtD
Verteporfin—Malaise—Bleomycin—melanoma	0.00381	0.00381	CcSEcCtD
Verteporfin—Cardiac disorder—Temozolomide—melanoma	0.0038	0.0038	CcSEcCtD
Verteporfin—Flushing—Temozolomide—melanoma	0.0038	0.0038	CcSEcCtD
Verteporfin—Dizziness—Vemurafenib—melanoma	0.00377	0.00377	CcSEcCtD
Verteporfin—Angiopathy—Temozolomide—melanoma	0.00372	0.00372	CcSEcCtD
Verteporfin—Immune system disorder—Temozolomide—melanoma	0.0037	0.0037	CcSEcCtD
Verteporfin—Malnutrition—Carmustine—melanoma	0.00369	0.00369	CcSEcCtD
Verteporfin—Cough—Bleomycin—melanoma	0.00369	0.00369	CcSEcCtD
Verteporfin—Ill-defined disorder—Dactinomycin—melanoma	0.00366	0.00366	CcSEcCtD
Verteporfin—Anaemia—Dactinomycin—melanoma	0.00364	0.00364	CcSEcCtD
Verteporfin—Liver function test abnormal—Docetaxel—melanoma	0.00364	0.00364	CcSEcCtD
Verteporfin—Chest pain—Bleomycin—melanoma	0.0036	0.0036	CcSEcCtD
Verteporfin—Rash—Vemurafenib—melanoma	0.00359	0.00359	CcSEcCtD
Verteporfin—Dermatitis—Vemurafenib—melanoma	0.00359	0.00359	CcSEcCtD
Verteporfin—Back pain—Carmustine—melanoma	0.00357	0.00357	CcSEcCtD
Verteporfin—Headache—Vemurafenib—melanoma	0.00357	0.00357	CcSEcCtD
Verteporfin—Malnutrition—Temozolomide—melanoma	0.00357	0.00357	CcSEcCtD
Verteporfin—Discomfort—Bleomycin—melanoma	0.00356	0.00356	CcSEcCtD
Verteporfin—Malaise—Dactinomycin—melanoma	0.00356	0.00356	CcSEcCtD
Verteporfin—Vision blurred—Carmustine—melanoma	0.00348	0.00348	CcSEcCtD
Verteporfin—Oedema—Bleomycin—melanoma	0.00345	0.00345	CcSEcCtD
Verteporfin—Back pain—Temozolomide—melanoma	0.00345	0.00345	CcSEcCtD
Verteporfin—Anaemia—Carmustine—melanoma	0.00341	0.00341	CcSEcCtD
Verteporfin—Nausea—Vemurafenib—melanoma	0.00338	0.00338	CcSEcCtD
Verteporfin—Vision blurred—Temozolomide—melanoma	0.00336	0.00336	CcSEcCtD
Verteporfin—Discomfort—Dactinomycin—melanoma	0.00332	0.00332	CcSEcCtD
Verteporfin—Ill-defined disorder—Temozolomide—melanoma	0.00331	0.00331	CcSEcCtD
Verteporfin—Anaemia—Temozolomide—melanoma	0.0033	0.0033	CcSEcCtD
Verteporfin—Oedema—Dactinomycin—melanoma	0.00322	0.00322	CcSEcCtD
Verteporfin—Malaise—Temozolomide—melanoma	0.00322	0.00322	CcSEcCtD
Verteporfin—Vertigo—Temozolomide—melanoma	0.0032	0.0032	CcSEcCtD
Verteporfin—Hypertension—Carmustine—melanoma	0.00319	0.00319	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00314	0.00314	CcSEcCtD
Verteporfin—Chest pain—Carmustine—melanoma	0.00314	0.00314	CcSEcCtD
Verteporfin—Cough—Temozolomide—melanoma	0.00311	0.00311	CcSEcCtD
Verteporfin—Hypertension—Temozolomide—melanoma	0.00308	0.00308	CcSEcCtD
Verteporfin—Dyspnoea—Bleomycin—melanoma	0.00308	0.00308	CcSEcCtD
Verteporfin—Pneumonia—Docetaxel—melanoma	0.00305	0.00305	CcSEcCtD
Verteporfin—Arthralgia—Temozolomide—melanoma	0.00304	0.00304	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00302	0.00302	CcSEcCtD
Verteporfin—Oedema—Carmustine—melanoma	0.00301	0.00301	CcSEcCtD
Verteporfin—Discomfort—Temozolomide—melanoma	0.003	0.003	CcSEcCtD
Verteporfin—Acute coronary syndrome—Docetaxel—melanoma	0.00299	0.00299	CcSEcCtD
Verteporfin—Myocardial infarction—Docetaxel—melanoma	0.00297	0.00297	CcSEcCtD
Verteporfin—Pain—Bleomycin—melanoma	0.00295	0.00295	CcSEcCtD
Verteporfin—Conjunctivitis—Docetaxel—melanoma	0.00295	0.00295	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00293	0.00293	CcSEcCtD
Verteporfin—Oedema—Temozolomide—melanoma	0.00291	0.00291	CcSEcCtD
Verteporfin—Nervous system disorder—Temozolomide—melanoma	0.00285	0.00285	CcSEcCtD
Verteporfin—Feeling abnormal—Bleomycin—melanoma	0.00284	0.00284	CcSEcCtD
Verteporfin—Skin disorder—Temozolomide—melanoma	0.00283	0.00283	CcSEcCtD
Verteporfin—Hyperhidrosis—Temozolomide—melanoma	0.00281	0.00281	CcSEcCtD
Verteporfin—Pain—Dactinomycin—melanoma	0.00275	0.00275	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Carmustine—melanoma	0.00274	0.00274	CcSEcCtD
Verteporfin—Urticaria—Bleomycin—melanoma	0.00274	0.00274	CcSEcCtD
Verteporfin—Haemoglobin—Docetaxel—melanoma	0.00274	0.00274	CcSEcCtD
Verteporfin—Body temperature increased—Bleomycin—melanoma	0.00273	0.00273	CcSEcCtD
Verteporfin—Haemorrhage—Docetaxel—melanoma	0.00272	0.00272	CcSEcCtD
Verteporfin—Hypoaesthesia—Docetaxel—melanoma	0.00271	0.00271	CcSEcCtD
Verteporfin—Pharyngitis—Docetaxel—melanoma	0.0027	0.0027	CcSEcCtD
Verteporfin—Dyspnoea—Carmustine—melanoma	0.00269	0.00269	CcSEcCtD
Verteporfin—Feeling abnormal—Dactinomycin—melanoma	0.00265	0.00265	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Temozolomide—melanoma	0.00265	0.00265	CcSEcCtD
Verteporfin—Visual impairment—Docetaxel—melanoma	0.00263	0.00263	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Carmustine—melanoma	0.0026	0.0026	CcSEcCtD
Verteporfin—Dyspnoea—Temozolomide—melanoma	0.00259	0.00259	CcSEcCtD
Verteporfin—Constipation—Carmustine—melanoma	0.00258	0.00258	CcSEcCtD
Verteporfin—Pain—Carmustine—melanoma	0.00258	0.00258	CcSEcCtD
Verteporfin—Eye disorder—Docetaxel—melanoma	0.00255	0.00255	CcSEcCtD
Verteporfin—Body temperature increased—Dactinomycin—melanoma	0.00254	0.00254	CcSEcCtD
Verteporfin—Hypersensitivity—Bleomycin—melanoma	0.00254	0.00254	CcSEcCtD
Verteporfin—Flushing—Docetaxel—melanoma	0.00253	0.00253	CcSEcCtD
Verteporfin—Cardiac disorder—Docetaxel—melanoma	0.00253	0.00253	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Temozolomide—melanoma	0.00251	0.00251	CcSEcCtD
Verteporfin—Constipation—Temozolomide—melanoma	0.00249	0.00249	CcSEcCtD
Verteporfin—Pain—Temozolomide—melanoma	0.00249	0.00249	CcSEcCtD
Verteporfin—Feeling abnormal—Carmustine—melanoma	0.00248	0.00248	CcSEcCtD
Verteporfin—Asthenia—Bleomycin—melanoma	0.00248	0.00248	CcSEcCtD
Verteporfin—Angiopathy—Docetaxel—melanoma	0.00247	0.00247	CcSEcCtD
Verteporfin—Immune system disorder—Docetaxel—melanoma	0.00246	0.00246	CcSEcCtD
Verteporfin—Pruritus—Bleomycin—melanoma	0.00244	0.00244	CcSEcCtD
Verteporfin—Feeling abnormal—Temozolomide—melanoma	0.0024	0.0024	CcSEcCtD
Verteporfin—Body temperature increased—Carmustine—melanoma	0.00238	0.00238	CcSEcCtD
Verteporfin—Malnutrition—Docetaxel—melanoma	0.00237	0.00237	CcSEcCtD
Verteporfin—Hypersensitivity—Dactinomycin—melanoma	0.00237	0.00237	CcSEcCtD
Verteporfin—Urticaria—Temozolomide—melanoma	0.00231	0.00231	CcSEcCtD
Verteporfin—Asthenia—Dactinomycin—melanoma	0.00231	0.00231	CcSEcCtD
Verteporfin—Body temperature increased—Temozolomide—melanoma	0.0023	0.0023	CcSEcCtD
Verteporfin—Back pain—Docetaxel—melanoma	0.00229	0.00229	CcSEcCtD
Verteporfin—Hypersensitivity—Carmustine—melanoma	0.00222	0.00222	CcSEcCtD
Verteporfin—Anaemia—Docetaxel—melanoma	0.00219	0.00219	CcSEcCtD
Verteporfin—Rash—Bleomycin—melanoma	0.00218	0.00218	CcSEcCtD
Verteporfin—Dermatitis—Bleomycin—melanoma	0.00217	0.00217	CcSEcCtD
Verteporfin—Asthenia—Carmustine—melanoma	0.00216	0.00216	CcSEcCtD
Verteporfin—Hypersensitivity—Temozolomide—melanoma	0.00214	0.00214	CcSEcCtD
Verteporfin—Syncope—Docetaxel—melanoma	0.00213	0.00213	CcSEcCtD
Verteporfin—Asthenia—Temozolomide—melanoma	0.00209	0.00209	CcSEcCtD
Verteporfin—Loss of consciousness—Docetaxel—melanoma	0.00208	0.00208	CcSEcCtD
Verteporfin—Cough—Docetaxel—melanoma	0.00207	0.00207	CcSEcCtD
Verteporfin—Pruritus—Temozolomide—melanoma	0.00206	0.00206	CcSEcCtD
Verteporfin—Nausea—Bleomycin—melanoma	0.00205	0.00205	CcSEcCtD
Verteporfin—Hypertension—Docetaxel—melanoma	0.00205	0.00205	CcSEcCtD
Verteporfin—Rash—Dactinomycin—melanoma	0.00203	0.00203	CcSEcCtD
Verteporfin—Arthralgia—Docetaxel—melanoma	0.00202	0.00202	CcSEcCtD
Verteporfin—Chest pain—Docetaxel—melanoma	0.00202	0.00202	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00201	0.00201	CcSEcCtD
Verteporfin—Dizziness—Carmustine—melanoma	0.00199	0.00199	CcSEcCtD
Verteporfin—Oedema—Docetaxel—melanoma	0.00194	0.00194	CcSEcCtD
Verteporfin—Dizziness—Temozolomide—melanoma	0.00192	0.00192	CcSEcCtD
Verteporfin—Nausea—Dactinomycin—melanoma	0.00191	0.00191	CcSEcCtD
Verteporfin—Shock—Docetaxel—melanoma	0.0019	0.0019	CcSEcCtD
Verteporfin—Rash—Carmustine—melanoma	0.0019	0.0019	CcSEcCtD
Verteporfin—Nervous system disorder—Docetaxel—melanoma	0.0019	0.0019	CcSEcCtD
Verteporfin—Dermatitis—Carmustine—melanoma	0.0019	0.0019	CcSEcCtD
Verteporfin—Headache—Carmustine—melanoma	0.00189	0.00189	CcSEcCtD
Verteporfin—Skin disorder—Docetaxel—melanoma	0.00188	0.00188	CcSEcCtD
Verteporfin—Rash—Temozolomide—melanoma	0.00184	0.00184	CcSEcCtD
Verteporfin—Dermatitis—Temozolomide—melanoma	0.00183	0.00183	CcSEcCtD
Verteporfin—Headache—Temozolomide—melanoma	0.00182	0.00182	CcSEcCtD
Verteporfin—Nausea—Carmustine—melanoma	0.00179	0.00179	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Docetaxel—melanoma	0.00176	0.00176	CcSEcCtD
Verteporfin—Nausea—Temozolomide—melanoma	0.00173	0.00173	CcSEcCtD
Verteporfin—Dyspnoea—Docetaxel—melanoma	0.00173	0.00173	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Docetaxel—melanoma	0.00167	0.00167	CcSEcCtD
Verteporfin—Pain—Docetaxel—melanoma	0.00166	0.00166	CcSEcCtD
Verteporfin—Constipation—Docetaxel—melanoma	0.00166	0.00166	CcSEcCtD
Verteporfin—Feeling abnormal—Docetaxel—melanoma	0.0016	0.0016	CcSEcCtD
Verteporfin—Body temperature increased—Docetaxel—melanoma	0.00153	0.00153	CcSEcCtD
Verteporfin—Hypersensitivity—Docetaxel—melanoma	0.00143	0.00143	CcSEcCtD
Verteporfin—Asthenia—Docetaxel—melanoma	0.00139	0.00139	CcSEcCtD
Verteporfin—Pruritus—Docetaxel—melanoma	0.00137	0.00137	CcSEcCtD
Verteporfin—Dizziness—Docetaxel—melanoma	0.00128	0.00128	CcSEcCtD
Verteporfin—Rash—Docetaxel—melanoma	0.00122	0.00122	CcSEcCtD
Verteporfin—Dermatitis—Docetaxel—melanoma	0.00122	0.00122	CcSEcCtD
Verteporfin—Headache—Docetaxel—melanoma	0.00121	0.00121	CcSEcCtD
Verteporfin—Nausea—Docetaxel—melanoma	0.00115	0.00115	CcSEcCtD
